Anaïs Glatard

发表

Influence of Renal Function Estimation on Pharmacokinetic Modeling of Vancomycin in Elderly Patients

R. Jelliffe, M. Neely, S. Goutelle, 2015, Antimicrobial Agents and Chemotherapy.

Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug development.

A. Berges, Chao Chen, E. Hénin, 2015, Toxicology and applied pharmacology.

Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug–drug interactions and probability of target attainment

T. Buclin, M. Cavassini, C. Marzolini, 2019, British journal of clinical pharmacology.

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication

K. Do, C. Eap, P. Conus, 2020, PloS one.

Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland.

M. Preisig, P. Vollenweider, C. Eap, 2020, The Journal of clinical psychiatry.

Valproate is associated with early decrease of high‐density lipoprotein cholesterol levels in the psychiatric population

C. Eap, A. von Gunten, P. Conus, 2021, Basic & clinical pharmacology & toxicology.

Association of Nicotine Metabolism and Sex With Relapse Following Varenicline and Nicotine Replacement Therapy

J. Cornuz, C. Eap, C. Csajka, 2017, Experimental and clinical psychopharmacology.

Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.

C. Eap, A. von Gunten, J. Aubry, 2017, Journal of clinical lipidology.

Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.

L. Applegate, C. Eap, A. von Gunten, 2017, Gene.

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients

C. Eap, A. von Gunten, P. Conus, 2019, Clinical Epigenetics.

Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs

C. Eap, A. von Gunten, P. Conus, 2017, Pharmacogenetics and genomics.

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances

M. Bochud, I. Guessous, C. Eap, 2018, Front. Psychiatry.

Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses

C. Eap, A. von Gunten, P. Conus, 2019, Clinical Pharmacokinetics.

Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population

J. Cornuz, C. Eap, C. Csajka, 2019, European Journal of Clinical Pharmacology.

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort

Z. Kutalik, C. Correll, C. Eap, 2021, Translational Psychiatry.

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients

C. Eap, A. von Gunten, P. Conus, 2019, Clinical Epigenetics.

P. Conus, C. Csajka, M. Guidi, 2019, Reactions Weekly.